NCT05252078
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Jiangxi Cancer Hospital Nanchang, Jiangxi, China
Clinical trial condition
Esophageal Squamous Cell Carcinoma
Explore clinical trials studying Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
205 public trials
78 recruiting studies
Esophageal Squamous Cell Carcinoma trial results
NCT05507411
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU) Hanzhou, Zhejiang, China
- Zhejiang Cancer Hospital Hanzhou, Zhejiang, China
- Ningbo Medical Center Lihuili Hospital Ningbo, Zhejiang, China
NCT04138212
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Henan Cancer Hospital Zhengzhou, Henan, China
NCT05392413
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Nanfang Hospital Guangzhou, China
NCT04807673
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Department of minimally invasive esophageal surgery, Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
NCT04009265
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
NCT04519905
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Chemoradiotherapy, +14 more
- Locations
-
- Jiangsu Cancer Hospital Nanjing, Jiangsu, China
- Huadong Hospital Shanghai, Shanghai Municipality, China
- Fudan Universtiy Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT04522687
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +15 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Enrolling by Invitation
Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma
NCT07312578
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Department of GI Oncology, Peking University Cancer Hospital, Beijing, Beijing Municipality, China
Enrolling by Invitation
Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma
NCT06303583
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China